Stephane Prost

Fontenay-sous-bois, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 10 publications

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

The AXL inhibitor bemcentinib overcomes microenvironment-mediated resistance to pioglitazone in acute myeloid leukemia.

Journal: The FEBS journal

Published: October 20, 2023

PPARγ agonists promote the resolution of myelofibrosis in preclinical models.

PPARγ agonists promote the resolution of myelofibrosis in preclinical models.

Journal: The Journal of clinical investigation

Published: January 23, 2020

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.

Pioglitazone together with imatinib in chronic myeloid leukemia: A proof of concept study.

Journal: Cancer

Published: October 07, 2016

What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?

What are the challenges in 2016 regarding resistance to tyrosine kinase inhibitors in chronic myeloid leukemia and cancer?

Journal: Hematological oncology

Published: May 31, 2016

Inhibition of the acetyl lysine-binding pocket of bromodomain and extraterminal domain proteins interferes with adipogenesis.

Inhibition of the acetyl lysine-binding pocket of bromodomain and extraterminal domain proteins interferes with adipogenesis.

Journal: Biochemical and biophysical research communications

Published: March 02, 2016

Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.

Transplantation of Macaca cynomolgus iPS-derived hematopoietic cells in NSG immunodeficient mice.

Journal: Haematologica

Published: June 20, 2015

Reply to J. Richter et al.

Reply to J. Richter et al.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: July 30, 2014

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Erosion of the chronic myeloid leukaemia stem cell pool by PPARγ agonists.

Journal: Nature

Published: March 17, 2014

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

Loss of major molecular response as a trigger for restarting tyrosine kinase inhibitor therapy in patients with chronic-phase chronic myelogenous leukemia who have stopped imatinib after durable undetectable disease.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: December 11, 2013

Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.

Stem cell factor-displaying simian immunodeficiency viral vectors together with a low conditioning regimen allow for long-term engraftment of gene-marked autologous hematopoietic stem cells in macaques.

Journal: Human gene therapy

Published: April 03, 2012

Showing 1-10 of 10

Last Updated: 09/26/2026